1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Genomiarket Size Growth Rate by Type: 2020 VS 2026
1.2.2 Assays and Kits
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Tumor Genomiarket Share by Application: 2020 VS 2026
1.3.2 Diagnostics and Monitoring
1.3.3 Drug Discovery and Development
1.3.4 Biomarker Discovery
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tumor Genomiarket Perspective (2015-2026)
2.2 Global Tumor Genomics Growth Trends by Regions
2.2.1 Tumor Genomiarket Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tumor Genomics Historic Market Share by Regions (2015-2020)
2.2.3 Tumor Genomics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Genomics Players by Market Size
3.1.1 Global Top Tumor Genomics Players by Revenue (2015-2020)
3.1.2 Global Tumor Genomics Revenue Market Share by Players (2015-2020)
3.2 Global Tumor Genomiarket Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tumor Genomics Revenue
3.4 Global Tumor Genomiarket Concentration Ratio
3.4.1 Global Tumor Genomiarket Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Genomics Revenue in 2019
3.5 Key Players Tumor Genomics Area Served
3.6 Key Players Tumor Genomics Product Solution and Service
3.7 Date of Enter into Tumor Genomiarket
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Genomics Breakdown Data by Type (2015-2026)
4.1 Global Tumor Genomics Historic Market Size by Type (2015-2020)
4.2 Global Tumor Genomics Forecasted Market Size by Type (2021-2026)
5 Tumor Genomics Breakdown Data by Application (2015-2026)
5.1 Global Tumor Genomics Historic Market Size by Application (2015-2020)
5.2 Global Tumor Genomics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tumor Genomiarket Size (2015-2026)
6.2 North America Tumor Genomiarket Size by Type (2015-2020)
6.3 North America Tumor Genomiarket Size by Application (2015-2020)
6.4 North America Tumor Genomiarket Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Tumor Genomiarket Size (2015-2026)
7.2 Europe Tumor Genomiarket Size by Type (2015-2020)
7.3 Europe Tumor Genomiarket Size by Application (2015-2020)
7.4 Europe Tumor Genomiarket Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Tumor Genomiarket Size (2015-2026)
8.2 China Tumor Genomiarket Size by Type (2015-2020)
8.3 China Tumor Genomiarket Size by Application (2015-2020)
8.4 China Tumor Genomiarket Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Tumor Genomiarket Size (2015-2026)
9.2 Japan Tumor Genomiarket Size by Type (2015-2020)
9.3 Japan Tumor Genomiarket Size by Application (2015-2020)
9.4 Japan Tumor Genomiarket Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Tumor Genomiarket Size (2015-2026)
10.2 Southeast Asia Tumor Genomiarket Size by Type (2015-2020)
10.3 Southeast Asia Tumor Genomiarket Size by Application (2015-2020)
10.4 Southeast Asia Tumor Genomiarket Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Company 1
11.1.1 Company 1 Company Details
11.1.2 Company 1 Business Overview
11.1.3 Company 1 Tumor Genomics Introduction
11.1.4 Company 1 Revenue in Tumor Genomics Business (2015-2020))
11.1.5 Company 1 Recent Development
11.2 Company 2
11.2.1 Company 2 Company Details
11.2.2 Company 2 Business Overview
11.2.3 Company 2 Tumor Genomics Introduction
11.2.4 Company 2 Revenue in Tumor Genomics Business (2015-2020)
11.2.5 Company 2 Recent Development
11.3 Company 3
11.3.1 Company 3 Company Details
11.3.2 Company 3 Business Overview
11.3.3 Company 3 Tumor Genomics Introduction
11.3.4 Company 3 Revenue in Tumor Genomics Business (2015-2020)
11.3.5 Company 3 Recent Development
11.4 Company 4
11.4.1 Company 4 Company Details
11.4.2 Company 4 Business Overview
11.4.3 Company 4 Tumor Genomics Introduction
11.4.4 Company 4 Revenue in Tumor Genomics Business (2015-2020)
11.4.5 Company 4 Recent Development
全球腫瘤基因組學行業研究和市場展望報告二零二零年至2026年
11.5 Company 5
11.5.1 Company 5 Company Details
11.5.2 Company 5 Business Overview
11.5.3 Company 5 Tumor Genomics Introduction
11.5.4 Company 5 Revenue in Tumor Genomics Business (2015-2020)
11.5.5 Company 5 Recent Development
11.6 Company 6
11.6.1 Company 6 Company Details
11.6.2 Company 6 Business Overview
11.6.3 Company 6 Tumor Genomics Introduction
11.6.4 Company 6 Revenue in Tumor Genomics Business (2015-2020)
11.6.5 Company 6 Recent Development
11.7 Company 7
11.7.1 Company 7 Company Details
11.7.2 Company 7 Business Overview
11.7.3 Company 7 Tumor Genomics Introduction
11.7.4 Company 7 Revenue in Tumor Genomics Business (2015-2020)
11.7.5 Company 7 Recent Development
11.8 Company 8
11.8.1 Company 8 Company Details
11.8.2 Company 8 Business Overview
11.8.3 Company 8 Tumor Genomics Introduction
11.8.4 Company 8 Revenue in Tumor Genomics Business (2015-2020)
11.8.5 Company 8 Recent Development
11.9 Company 9
11.9.1 Company 9 Company Details
11.9.2 Company 9 Business Overview
11.9.3 Company 9 Tumor Genomics Introduction
11.9.4 Company 9 Revenue in Tumor Genomics Business (2015-2020)
11.9.5 Company 9 Recent Development
11.10 Company 10
11.10.1 Company 10 Company Details
11.10.2 Company 10 Business Overview
11.10.3 Company 10 Tumor Genomics Introduction
11.10.4 Company 10 Revenue in Tumor Genomics Business (2015-2020)
11.10.5 Company 10 Recent Development
11.11 Company 11
10.11.1 Company 11 Company Details
10.11.2 Company 11 Business Overview
10.11.3 Company 11 Tumor Genomics Introduction
10.11.4 Company 11 Revenue in Tumor Genomics Business (2015-2020)
10.11.5 Company 11 Recent Development
11.12 Company 12
10.12.1 Company 12 Company Details
10.12.2 Company 12 Business Overview
10.12.3 Company 12 Tumor Genomics Introduction
10.12.4 Company 12 Revenue in Tumor Genomics Business (2015-2020)
10.12.5 Company 12 Recent Development
11.13 Company 13
10.13.1 Company 13 Company Details
10.13.2 Company 13 Business Overview
10.13.3 Company 13 Tumor Genomics Introduction
10.13.4 Company 13 Revenue in Tumor Genomics Business (2015-2020)
10.13.5 Company 13 Recent Development
11.14 Company 14
10.14.1 Company 14 Company Details
10.14.2 Company 14 Business Overview
10.14.3 Company 14 Tumor Genomics Introduction
10.14.4 Company 14 Revenue in Tumor Genomics Business (2015-2020)
10.14.5 Company 14 Recent Development
11.15 Company 15
10.15.1 Company 15 Company Details
10.15.2 Company 15 Business Overview
10.15.3 Company 15 Tumor Genomics Introduction
10.15.4 Company 15 Revenue in Tumor Genomics Business (2015-2020)
10.15.5 Company 15 Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Tumor Genomiarket Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Assays and Kits
Table 4. Key Players of Instrument
全球腫瘤基因組學行業研究和市場展望報告二零二零年至2026年
Table 5. Global Tumor Genomiarket Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Tumor Genomiarket Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Tumor Genomiarket Size by Regions (2015-2020) (US$ Million)
Table 8. Global Tumor Genomiarket Share by Regions (2015-2020)
Table 9. Global Tumor Genomics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Tumor Genomiarket Share by Regions (2021-2026)
Table 11. Tumor Genomiarket Market Trends
Table 12. Tumor Genomiarket Drivers
Table 13. Tumor Genomiarket Challenges
Table 14. Tumor Genomiarket Restraints
Table 15. Global Tumor Genomics Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Tumor Genomiarket Share by Players (2015-2020)
Table 17. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Genomics as of 2019)
Table 18. Global Tumor Genomics by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tumor Genomics Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Tumor Genomiarket Size by Type (2015-2020) (US$ Million)
Table 23. Global Tumor Genomiarket Size Share by Type (2015-2020)
Table 24. Global Tumor Genomics Revenue Market Share by Type (2021-2026)
Table 25. Global Tumor Genomiarket Size Share by Application (2015-2020)
Table 26. Global Tumor Genomiarket Size by Application (2015-2020) (US$ Million)
Table 27. Global Tumor Genomiarket Size Share by Application (2021-2026)
Table 28. North America Tumor Genomiarket Size by Type (2015-2020) (US$ Million)
Table 29. North America Tumor Genomiarket Share by Type (2015-2020)
Table 30. North America Tumor Genomiarket Size by Application (2015-2020) (US$ Million)
Table 31. North America Tumor Genomiarket Share by Application (2015-2020)
Table 32. North America Tumor Genomiarket Size by Country (US$ Million) (2015-2020)
Table 33. North America Tumor Genomiarket Share by Country (2015-2020)
Table 34. Europe Tumor Genomiarket Size by Type (2015-2020) (US$ Million)
Table 35. Europe Tumor Genomiarket Share by Type (2015-2020)
Table 36. Europe Tumor Genomiarket Size by Application (2015-2020) (US$ Million)
Table 37. Europe Tumor Genomiarket Share by Application (2015-2020)
Table 38. Europe Tumor Genomiarket Size by Country (US$ Million) (2015-2020)
Table 39. Europe Tumor Genomiarket Share by Country (2015-2020)
Table 40. China Tumor Genomiarket Size by Type (2015-2020) (US$ Million)
Table 41. China Tumor Genomiarket Share by Type (2015-2020)
Table 42. China Tumor Genomiarket Size by Application (2015-2020) (US$ Million)
Table 43. China Tumor Genomiarket Share by Application (2015-2020)
Table 44. China Tumor Genomiarket Size by Region (US$ Million) (2015-2020)
Table 45. China Tumor Genomiarket Share by Region (2015-2020)
Table 46. Japan Tumor Genomiarket Size by Type (2015-2020) (US$ Million)
Table 47. Japan Tumor Genomiarket Share by Type (2015-2020)
Table 48. Japan Tumor Genomiarket Size by Application (2015-2020) (US$ Million)
Table 49. Japan Tumor Genomiarket Share by Application (2015-2020)
Table 50. Japan Tumor Genomiarket Size by Country (US$ Million) (2015-2020)
Table 51. Japan Tumor Genomiarket Share by Country (2015-2020)
Table 52. Southeast Asia Tumor Genomiarket Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Tumor Genomiarket Share by Type (2015-2020)
Table 54. Southeast Asia Tumor Genomiarket Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Tumor Genomiarket Share by Application (2015-2020)
Table 56. Southeast Asia Tumor Genomiarket Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Tumor Genomiarket Share by Country (2015-2020)
Table 58. Company 1 Company Details
Table 59. Company 1 Business Overview
Table 60. Company 1 Product
Table 61. Company 1 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 62. Company 1 Recent Development
Table 63. Company 2 Company Details
Table 64. Company 2 Business Overview
Table 65. Company 2 Product
Table 66. Company 2 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 67. Company 2 Recent Development
Table 68. Company 3 Company Details
Table 69. Company 3 Business Overview
Table 70. Company 3 Product
Table 71. Company 3 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 72. Company 3 Recent Development
Table 73. Company 4 Company Details
Table 74. Company 4 Business Overview
Table 75. Company 4 Product
Table 76. Company 4 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 77. Company 4 Recent Development
Table 78. Company 5 Company Details
quánqiú zhǒngliú jīyīnzǔ xué hángyè yánjiū hé shìchǎng zhǎnwàng bàogào èr líng èr líng nián zhì 2026 nián
Table 79. Company 5 Business Overview
Table 80. Company 5 Product
Table 81. Company 5 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 82. Company 5 Recent Development
Table 83. Company 6 Company Details
Table 84. Company 6 Business Overview
Table 85. Company 6 Product
Table 86. Company 6 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 87. Company 6 Recent Development
Table 88. Company 7 Company Details
Table 89. Company 7 Business Overview
Table 90. Company 7 Product
Table 91. Company 7 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 92. Company 7 Recent Development
Table 93. Company 8 Business Overview
Table 94. Company 8 Product
Table 95. Company 8 Company Details
Table 96. Company 8 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 97. Company 8 Recent Development
Table 98. Company 9 Company Details
Table 99. Company 9 Business Overview
Table 100. Company 9 Product
Table 101. Company 9 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 102. Company 9 Recent Development
Table 103. Company 10 Company Details
Table 104. Company 10 Business Overview
Table 105. Company 10 Product
Table 106. Company 10 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 107. Company 10 Recent Development
Table 108. Company 11 Company Details
Table 109. Company 11 Business Overview
Table 110. Company 11 Product
Table 111. Company 11 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 112. Company 11 Recent Development
Table 113. Company 12 Company Details
Table 114. Company 12 Business Overview
Table 115. Company 12 Product
Table 116. Company 12 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 117. Company 12 Recent Development
Table 118. Company 13 Company Details
Table 119. Company 13 Business Overview
Table 120. Company 13 Product
Table 121. Company 13 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 122. Company 13 Recent Development
Table 123. Company 14 Company Details
Table 124. Company 14 Business Overview
Table 125. Company 14 Product
Table 126. Company 14 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 127. Company 14 Recent Development
Table 128. Company 15 Company Details
Table 129. Company 15 Business Overview
Table 130. Company 15 Product
Table 131. Company 15 Revenue in Tumor Genomics Business (2015-2020) (US$ Million)
Table 132. Company 15 Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Genomiarket Share by Type: 2020 VS 2026
Figure 2. Assays and Kits Features
Figure 3. Instrument Features
Figure 4. Global Tumor Genomiarket Share by Application: 2020 VS 2026
Figure 5. Diagnostics and Monitoring Case Studies
Figure 6. Drug Discovery and Development Case Studies
Figure 7. Biomarker Discovery Case Studies
Figure 8. Tumor Genomics Report Years Considered
Figure 9. Global Tumor Genomiarket Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Tumor Genomiarket Share by Regions: 2020 VS 2026
Figure 11. Global Tumor Genomiarket Share by Regions (2021-2026)
Figure 12. Global Tumor Genomiarket Share by Players in 2019
Figure 13. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Genomics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Tumor Genomics Revenue in 2019
Figure 15. North America Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
グローバル腫瘍ゲノミクス業界の研究と市場展望レポート2020-2026
Figure 19. Germany Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Tumor Genomiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Company 1 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 43. Company 2 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 44. Company 3 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 45. Company 4 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 46. Company 5 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 47. Company 6 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 48. Company 7 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 49. Company 8 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 50. Company 9 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 51. Company 10 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 52. Company 11 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 53. Company 12 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 54. Company 13 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 55. Company 14 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 56. Company 15 Revenue Growth Rate in Tumor Genomics Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
省略………
請撥打：400 612 8668、010-6618 1099、66182099、66183099
Email：KF@Cir.cn 下載《訂購協議》 ┊ 【網上訂購】 ┊ 了解“訂購流程”
京公網安備 11010802027365號